Dekkers Marijn E
- SEC CIK
- 0001216068
No open-market purchases or sales filed in the past year.
Current role at each company
- CERE Cerevel Therapeutics Holdings, Inc.Directoras of Aug 5, 2024
- DNA Ginkgo Bioworks Holdings, Inc.Directoras of Jun 14, 2024
- QSI Quantum-Si IncDirectoras of May 13, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Dekkers Marijn E as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
DNA Ginkgo Bioworks Holdings, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 20, 2024 (view filing) | May 16 | 4 days | Dekkers Marijn EDirector | SSaleClass A Common Stock | −265.0K | $0.83 | −$219.9K | −4.6%5.52M after | |
| May 14, 2024 (view filing) | May 14 | Same day | Dekkers Marijn EDirector | SSaleClass A Common Stock | −1.73M | $0.93 | −$1.61M | −86.0%281.2K after | |
| Nov 7, 2022 (view filing) | Nov 3 | 4 days | Dekkers Marijn EDirector | SSaleClass A Common Stock | −171.5K | $2.56 | −$438.9K | −7.8%2.02M after |
CERE Cerevel Therapeutics Holdings, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 20, 2023 (view filing) | Jun 15 | 5 days | Dekkers Marijn EDirector | SSale | −200.0K | $34.43 | −$6.89M | −33.2%402.3K after |